Leonardo Vazquez

Dr. Leonardo Vazquez

orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 December 2021 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
OCOtávio Chaves
Otávio Chaves
Carolina SacramentoCarolina Sacramento
Carolina Sacramento
AFAndré Costa Ferreira
André Costa Ferreira
MMMayara Mattos
Mayara Mattos
NFNatalia Fintelman-Rodrigues
Natalia Fintelman-Rodrigues
TSThiago Moreno Lopes e Souza
Thiago Moreno Lopes e Souza
Atazanavir (ATV) has already been considered as a potential repurposing drug to 2019 coronavirus disease (COVID-19); however, there are controversial reports on its mechanism of action and effectiveness as anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Through the pre-clinical chain of experiments: enzymatic, molecular docking, cell-based and in vivo assays, it is demonstrated here that both SARS-CoV-2 B.1 lineage and variant of concern gamma are susceptible to this antiretroviral. Enzymatic assays and molecular docking calculations showed that SARS-CoV-2 main protease (Mpro) was inhibited by ATV, with Morrison’s inhibitory constant (Ki) 1.5-fold higher than GC376 (a positive control) dependent of the catalytic water (H2Ocat) content. ATV was a competitive inhibitor, increasing the Mpro’s Michaelis–Menten (Km) more than sixfold. Cell-based assays indicated that different lineages of SARS-CoV-2 is susceptible to ATV. Using oral administration of ATV in mice to reach plasmatic exposure similar to humans, transgenic mice expression in human angiotensin converting enzyme 2 (K18-hACE2) were partially protected against lethal challenge with SARS-CoV-2 gamma. Moreover, less cell death and inflammation were observed in the lung from infected and treated mice. Our studies may contribute to a better comprehension of the Mpro/ATV interaction, which could pave the way to the development of specific inhibitors of this viral protease.

7 June 2024 in Scientia Pharmaceutica
Verified
Journal Article
Open access
PDF file
MSMarilia Amavel Gomes Soares
Marilia Amavel Gomes Soares
FSFranklin Souza Silva
Franklin Souza Silva
Carlos Roberto AlvesCarlos Roberto Alves
Carlos Roberto Alves
LVLeonardo Vazquez
Leonardo Vazquez
TATalita Stelling de Araujo
Talita Stelling de Araujo
OCOtávio Chaves
Otávio Chaves
Cardiovascular diseases (CVDs), especially arterial hypertension, stand as prominent contributors to global mortality. Regrettably, individuals with diabetes encounter a two-fold increase in the risk of mortality associated with CVDs. Hydrochlorothiazide (HCTZ) represents a primary intervention for hypertension, particularly in diabetic patients. Nevertheless, there has not yet been a comprehensive assessment of the biophysical characteristics regarding the impact of glucose levels on its binding affinity with human serum albumin (HSA). Thus, the present work reports the interactive profile of HSA/HCTZ in nonglycemic, normoglycemic (80 mg/dL), and hyperglycemic (320 mg/dL) conditions by time-resolved fluorescence, saturation transfer difference–nuclear magnetic resonance (STD-NMR), and surface plasmon resonance (SPR). There was a moderate ground state association of HSA/HCTZ with subdomain IIA that was affected in the presence of different glucose levels. The hyperglycemic condition decreased the binding affinity of HCTZ to subdomain IIA and increased the possibility of subdomain IB also being considered as a secondary binding site due to cooperativity and/or alterations in the protein’s structure. Overall, the glucose level under hyperglycemic conditions led to the cavities being more likely to receive more ligands, offering insights into the necessity of glucose control in the human bloodstream to not impact the residence time (pharmacokinetic profile) and pharmacotherapeutic potential of HCTZ.

30 June 2021 in European Journal of Chemistry
Verified
Journal Article
Open access
PDF file
OCOtávio Chaves
Otávio Chaves
LVLeonardo Vazquez
Leonardo Vazquez
Fluoroquinolones are a family of broad spectrum, systemic antibacterial agents that have been used as therapy for infections in the respiratory and alimentary tract in animals. The pharmacodynamic of this class is widely described, predominantly to the commercial drugs ciprofloxacin (CIP), enrofloxacin (ENR), and pefloxacin (PEF). Bovine serum albumin (BSA) is the main endogenous carrier in the bovine bloodstream, being responsible for the biodistribution of different classes of molecules and drugs, including fluoroquinolones. The molecular features and interaction between BSA and fluoroquinolones are not fully described, thus, the present work enlightens the intimacy of the interaction of BSA with CIP, ENR, PEF through structural modeling and molecular docking calculation approaches. The role of key amino acid residues was assessed, indicating that the main protein binding pocket is composed by Trp-212 residue playing an important stabilization for the three fluoroquinolones through both hydrogen bonding and van der Waals forces, where reside the individual structural differences observed among the three fluoroquinolones and BSA. There is a descriptive protagonism of carboxyl group on the ENR interaction which traps the molecule and avoids the deep communication in the protein binding pocket, as well as the ligands CIP and PEF showed an interface amino acid residue interaction profile higher than 70%.

1 January 2009 in Environmental Engineering and Management Journal
Verified
Journal Article
Closed access
FOFernando Jorge Santos Oliveira
Fernando Jorge Santos Oliveira
LVLeonardo Vazquez
Leonardo Vazquez
FFFrancisca Pessoa de Franca
Francisca Pessoa de Franca

27 November 2025 in bioRxiv
Verified
Preprint
Open access
RRRodiésley S. Rosa
Rodiésley S. Rosa
AMAna Paula M. Mendonça
Ana Paula M. Mendonça
MOMarcus F. Oliveira
Marcus F. Oliveira
DCDanielle B. Carvalho
Danielle B. Carvalho
LVLeonardo Vazquez
Leonardo Vazquez
MOMarcus F. Oliveira
Marcus F. Oliveira
The fruit fly Drosophila melanogaster is a valuable model for studying cellular and metabolic processes conserved with mammals. Using its embryonic Schneider S2 cell line, commonly used for heterologous protein expression, we investigated how culture duration and slight temperature changes affect mitochondrial physiology via high-resolution respirometry. We assessed five mitochondrial bioenergetic parameters and two coupling parameters at early and late growth phases, and at two temperatures (26°C and 28°C). We observed that a moderate temperature increase coupled with late growth phase synergistically enhanced basal, OXPHOS, and leak respiration, with only minor impacts on mitochondrial coupling efficiency. Notably, spare and maximal respiratory capacities increased disproportionately with either cell growth progression or moderate temperature rise, suggestive of enhanced mitochondrial biogenesis. These results demonstrate that small temperature increases and cell maturation activate mitochondrial bioenergetic capacity through mechanisms consistent with mitochondrial biogenesis and functional remodeling. Such adaptations improve cellular metabolic resilience while maintaining energy conversion efficiency. These findings deepen understanding of mitochondrial plasticity in response to environmental and developmental signals. They may inform strategies to optimize mitochondrial physiology in various biological contexts, including aging, metabolic diseases, and stress adaptation.